Central Pharmaceuticals Ltd. (DSE:CENTRALPHL)
9.40
-0.10 (-1.05%)
At close: Sep 24, 2026
Central Pharmaceuticals Market Cap
Central Pharmaceuticals has a market cap or net worth of 1.13 billion as of September 25, 2026. Its market cap has decreased by -6.00% in one year.
Market Cap
1.13B
Enterprise Value
1.39B
Revenue
36.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.40
ChartMarket Cap Chart
Since August 14, 2013, Central Pharmaceuticals's market cap has decreased from 2.38B to 1.13B, a decrease of -52.70%. That is a compound annual growth rate of -5.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 1.13B | 9.30% |
| Dec 30, 2025 | 1.03B | -3.37% |
| Dec 30, 2024 | 1.07B | -55.94% |
| Dec 28, 2023 | 2.42B | 69.75% |
| Dec 29, 2022 | 1.43B | -9.85% |
| Dec 30, 2021 | 1.58B | 9.09% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| The IBN SINA Pharmaceutical Industry | 9.94B |
| Navana Pharmaceuticals | 6.94B |
| Orion Pharma | 6.44B |
| Techno Drugs | 5.40B |
| Silco Pharmaceuticals | 1.85B |
| Silva Pharmaceuticals | 1.83B |
| Ambee Pharmaceuticals | 1.83B |
| Indo-Bangla Pharmaceuticals | 1.81B |